Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Broadcom, Microsoft, IBM, Meta, Tyson Foods & more
Wall Street analysts issued multiple calls Monday. Goldman initiated HawkEye 360 as buy; Morgan Stanley upgraded Dell to equal weight; Wells Fargo upgraded Tandem Diabetes Care to overweight. Citizens initiated Microsoft at Market Outperform with a $550 target; Barclays initiated IBM at overweight with a $350 target. Cantor reiterated Tesla overweight; RBC reiterated Meta outperform. Broadcom was reiterated overweight by Morgan Stanley, raising its target to $485.
How this was made
The 30-second read
Why it matters
This is a sentiment/positioning catalyst set rather than a single-company fundamental event; the most actionable items are those tied to upcoming earnings (AVGO) or specific company-disclosed operational details (TSLA Optimus production line).
Market read
Traders can use the calls to gauge near-term sentiment and pre-earnings positioning, but most items are thesis-based without fresh company data.
What to watch
Key risk is execution vs thesis: e.g., Optimus ramp credibility (TSLA), AI networking/TPU demand durability into earnings (AVGO), and DCF assumption sensitivity (Z).
Background
CNBC compiles Monday’s largest Wall Street analyst calls, including multiple initiations and upgrades across mega-cap tech, autos/robotics, semis/AI networking, medtech, software security, and thematic rare-earth/drone/cruise names.
Ticker impact
Cantor Fitzgerald adds Nvidia to its best ideas list, citing durable AI-accelerated computing advantage across GPUs, networking, and software.
Mild positive bias; likely limited follow-through unless paired with fresh fundamentals.
This is an analyst conviction call rather than company-reported results or guidance.
Citi reiterates Apple as buy, incrementally positive on iPhone shipments and expecting share gains amid memory pricing pressure.
Moderately positive drift possible if market is positioned for weaker iPhone demand.
The article provides a clear thesis (shipments/share) but not new Apple-specific operational data.
Cantor Fitzgerald reiterates Tesla as overweight, bullish on humanoid robots and citing an installed Optimus production line in California.
Positive near-term sentiment; magnitude depends on how investors weigh Optimus vs autos margins.
The call references a specific Q1 disclosed production-line installation and stated 1M annual capacity expectation.
Morgan Stanley reiterates Broadcom as overweight and raised its price target ahead of Broadcom earnings, citing strong AI networking checks and TPU demand.
Upward bias into earnings; volatility possible if results miss high expectations.
The article explicitly ties the PT raise to pre-quarter AI networking/TPU demand checks and upcoming earnings.
Citizens initiates Microsoft with Market Outperform and a $550 price target, stating the stock is down ~7% YTD.
Mild-to-moderate positive bias over days/weeks.
No new Microsoft operational metric is provided; impact is primarily from analyst initiation.
Barclays initiates IBM at overweight with a $350 price target, highlighting a stable growth engine built on its software portfolio.
Gradual positive drift rather than a sharp move.
This is a valuation/thesis initiation without new IBM performance data.
RBC reiterates Meta as outperform, arguing the stock is undervalued at the intersection of compute capacity and AI-enabled entrepreneurship trends.
Moderately positive bias; likely sentiment-driven.
The article is thesis-based and does not cite new META KPIs.
Citi upgrades Tandem Diabetes Care to overweight from equal weight, citing attractive risk/reward.
Short-term positive bias; follow-through depends on upcoming company-specific catalysts.
The article provides the rating change but limited new Tandem fundamentals.
Market effects
AI infrastructure/semis (NVDA/AVGO/MSFT) and critical minerals (MP/USA) receive bullish analyst framing, supporting risk appetite in those themes.
Primarily US-listed equities; sentiment spillover to US growth/AI complex.
Rare-earth diversification narrative ties to Western supply-chain policy themes, relevant to global industrial/materials demand expectations.
Counterpoint
Analyst PTs/upgrades in a roundup can be crowded; without new company-reported metrics, price action may fade quickly after initial positioning.
Key entities
- broker/analystGoldman Sachs
Initiates HawkEye 360 and Suja Life; adds Block and Tyson Foods to conviction list.
- broker/analystMorgan Stanley
Upgrades Dell (not included) and reiterates Broadcom ahead of earnings with a raised price target.
- broker/analystCantor Fitzgerald
Reiterates Tesla overweight on humanoid robot production ramp; reiterates Tesla.
- broker/analystCiti
Upgrades Tandem Diabetes Care and Kohl’s; reiterates Apple as buy and initiates/frames multiple consumer/health names.
